This proposal is for a five-year renewal of the Alzheimer's Disease Research Center at the University of California at San Diego (UCSD) in consortium with the Salk Institute. The major objective of our ADRC is to enhance research into Alzheimer's disease (AD), a disorder which is a major disabling disease of the elderly accounting for half of nursing home admissions as well as increasing mortality rate and impacting severely upon families and caregivers. We have sought to enlist investigators and develop resources necessary to move forward in a significant way in the understanding of the pathogenesis and pathophysiology of AD with the ultimate goal of learning enough about the disease to be able to prevent or alter its clinical course, at the same time improving our understanding of the clinical diagnosis, course and the relationship of neuropsychological dysfunction to specific brain lesions. The ADRC provides a clinical and neuropathological resource based upon annual evaluations of a cohort of volunteers willing to participate in clinical research, subjects with Alzheimer's disease and related disorders and normal aged matched volunteers. The Clinical Core activity provides subjects for research and pilot projects and also permits study of clinical and neuropsychological changes during the course of AD; forms the base for development of cross- cultural studies of AD, specifically, Hispanic, Chinese and Finnish studies; enables participation in multicenter drug studies and national registries such as CERAD and THA; generates a well edited longitudinal data base. The Neuropathological Core provides a source of brain tissue of patients characterized clinically and neuropathologically for use in research projects. The ADRC provides a setting to facilitate research training of AD investigators and information transfer to the professional and lay communities through our mini-residency program, conferences and other educational activities. We foster interdisciplinary research activities through collaborations, seminars, feasibility and pilot projects. Our specific research projects in this renewal include investigations of the precursor protein for the Beta amyloid present in neuritic plaques (Research Project 1); the specific nature of the memory and other cognitive deficits in the Alzheimer process (Research Project 2); the quantitative anatomical study of Alzheimer brain in regard to neuronal populations in dementia (Research Project 3); and the effect of nerve growth factor as a potential therapeutic modality (Research Project 4); The UCSD ADRC fosters new research initiatives through pilot and feasibility projects which span disciplines from electronmicroscopy to electrophysiology, from clinical psychiatry to neuro-ophthalmology and which involve faculty at neighboring institutions in San Diego as well as at UCSD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005131-10
Application #
3104719
Study Section
Aging Review Committee (AGE)
Project Start
1984-09-28
Project End
1994-03-31
Budget Start
1993-04-15
Budget End
1994-03-31
Support Year
10
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Brenowitz, Willa D; Han, Fang; Kukull, Walter A et al. (2018) Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. Neurobiol Aging 62:64-71
Blue, Elizabeth E; Bis, Joshua C; Dorschner, Michael O et al. (2018) Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project. Dement Geriatr Cogn Disord 45:1-17
Gallagher, Damien; Kiss, Alex; Lanctot, Krista L et al. (2018) Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors. J Clin Psychiatry 80:
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Golde, Todd E; DeKosky, Steven T; Galasko, Douglas (2018) Alzheimer's disease: The right drug, the right time. Science 362:1250-1251
Young, Jessica E; Fong, Lauren K; Frankowski, Harald et al. (2018) Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer's Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein. Stem Cell Reports 10:1046-1058
Reas, Emilie T; Hagler Jr, Donald J; White, Nathan S et al. (2018) Microstructural brain changes track cognitive decline in mild cognitive impairment. Neuroimage Clin 20:883-891
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Graves, Lisa V; Holden, Heather M; Van Etten, Emily J et al. (2018) New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer's and Huntington's Disease. J Int Neuropsychol Soc 24:833-841
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307

Showing the most recent 10 out of 914 publications